Adit Ben‐Baruch

Tel Aviv University — Israel

Medicine · Health Sciences

48h-index9.2kcitations102works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chemokine receptors and signaling(70), Immunotherapy and Immune Responses(45), Cell Adhesion Molecules Research(25), Immune cells in cancer(22), Cytokine Signaling Pathways and Interactions(19)

Publications102 total

Chemokine receptors in GtoPdb v.2025.3
IUPHAR/BPS Guide to Pharmacology CITE·2025Open Access
N-glycosylation of PD-L1 modulates the efficacy of immune checkpoint blockades targeting PD-L1 and PD-1
Molecular Cancer·2025· 5 citedOpen Access
Chemokine receptors in GtoPdb v.2025.1
IUPHAR/BPS Guide to Pharmacology CITE·2025Open Access
Partners in crime: TNFα-based networks promoting cancer progression.
South East European Journal of Immunology·2025· 1 citedOpen Access
The Tumor Immune Environment: Advances in the Cancer Immunotherapy Era
Methods in molecular biology·2025· 3 cited
Effect of aberrant N-glycosylation of PD-L1 on the potency of anti-PD-1 treatments.
Journal of Clinical Oncology·2024
The Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Breast Cancer Are Regulated by N-Linked Glycosylation-Dependent Activation of STAT3 and STAT1
Cells·2023· 11 citedOpen Access
Chemokine receptors in GtoPdb v.2023.1
IUPHAR/BPS Guide to Pharmacology CITE·2023· 2 citedOpen Access
A Tumor Microenvironment-Driven Network Regulated by STAT3 and p65 Negatively Controls the Enrichment of Cancer Stem Cells in Human HR+/HER2− Breast Cancer
Cancers·2023· 27 citedOpen Access
Inflammation-Driven Regulation of PD-L1 and PD-L2, and Their Cross-Interactions with Protective Soluble TNFα Receptors in Human Triple-Negative Breast Cancer
Cancers·2022· 11 citedOpen Access
Correction: Erlichman et al. Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes. Cancers 2022, 14, 1042
Cancers·2022· 2 citedOpen Access
Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy
Frontiers in Immunology·2022· 48 citedOpen Access
Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes
Cancers·2022· 19 citedOpen Access
Chemotherapy Shifts the Balance in Favor of CD8+ TNFR2+ TILs in Triple-Negative Breast Tumors
Cells·2021· 10 citedOpen Access
Continuous Inflammatory Stimulation Leads via Metabolic Plasticity to a Prometastatic Phenotype in Triple-Negative Breast Cancer Cells
Cells·2021· 16 citedOpen Access
Persistent Inflammatory Stimulation Drives the Conversion of MSCs to Inflammatory CAFs That Promote Pro-Metastatic Characteristics in Breast Cancer Cells
Cancers·2021· 48 citedOpen Access
Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy
Frontiers in Oncology·2021· 52 citedOpen Access
Chemokine receptors (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database
IUPHAR/BPS Guide to Pharmacology CITE·2020· 3 citedOpen Access
Notch-Inflammation Networks in Regulation of Breast Cancer Progression
Cells·2020· 23 citedOpen Access
Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy
Frontiers in Immunology·2020· 139 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Tsipi Meshel(14), Joost J. Oppenheim(10), Rotem Feniger-Barish(6), Elina Azenshtein(5), Sima Shina(5), Iafa Keydar(5), Leonor Leider–Trejo(5), O. M. Zack Howard(5), Yulia Liubomirski(5), Ji Ming Wang(5), Gali Soria(4), Orit Sagi‐Assif(4), Isaac P. Witz(4), Shalom Lerrer(4), Linor Rubinstein-Achiasaf(4), Dina Morein(4), Eran Neumark(3), Neora Yaal‐Hahoshen(3), Michael Grimm(3), Dennis D. Taub(3)